KIORA PHARMACEUTICALS INC (KPRX)

US49721T3095 - Common Stock

0.5795  +0.09 (+19.48%)

After market: 0.502 -0.08 (-13.37%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.0010.00K2.69M
Minority Interest Expense
N/AN/AN/AN/AN/A
Operating Expenses
10.68M12.31M10.20M8.22M9.80M
Research and Development
4.03M3.45M5.35M3.57M5.39M
Selling, General, and Administrative Expenses
4.66M8.28M5.32M4.66M4.41M
Operating Income
-10.68M-12.31M-10.20M-8.21M-7.11M
Interest Income/Expense
162.86K-1.39M-10.00K20.00K110.00K
Other Income/Expense
28.84KN/A-30.00KN/AN/A
Non Recurring Items
-1.90M0.00-3.76M110.00KN/A
Income Before Taxes
-12.42M-13.70M-13.96M-8.08M-7.00M
Income Tax
90.32K-110.00K-190.00K10.00K100.00K
Net Income
-13.04M-13.58M-13.77M-8.09M-7.10M
EBITDA
-10.63M-12.27M-10.15M-8.18M-7.06M
 
Per Share Data
EPS Diluted Total Ops
-2.69-18.60-57.37-73.54-88.75
Non GAAP EPS
-3.15-25.79-66.87N/AN/A
 
Statistics
Profit Margin
N/AN/AN/A-80900.00%-263.94%
Operating Profit Margin
N/AN/AN/A-82100.00%-264.31%

All data in USD

Charts